Let's Go to the Videotape: Promoting the visibility and understanding of regulatory science by using case studies from publicly available FDA information

摘要

Almost 10 years ago, the United States Food and Drug Administration (FDA) recognized the need to stimulate the pace of innovation in drug and biologics development when it issued its 2006 report on "Innovation/Stagnation-Challenge and Opportunity on the Critical Path to New Medical Products" (http://bit.ly/2iuK9bg).